Single center study to determine the incidence of second primary neoplasia in a cohort of chronic lymphocytic leukemia patients
Latest Information Update: 21 Jan 2021
At a glance
- Drugs Acalabrutinib (Primary) ; Ibrutinib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
Most Recent Events
- 01 Dec 2020 Results published in the Leukemia
- 05 Sep 2019 New trial record